Severe bullous pemphigoid in a metastatic lung cancer patient treated with pembrolizumab

J Dermatol. 2019 Jul;46(7):e232-e233. doi: 10.1111/1346-8138.14813. Epub 2019 Feb 13.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged, 80 and over
  • Antibodies, Monoclonal, Humanized / adverse effects*
  • Antineoplastic Agents, Immunological / adverse effects*
  • Humans
  • Leg
  • Lung Neoplasms / drug therapy*
  • Lung Neoplasms / pathology
  • Male
  • Pemphigoid, Bullous / chemically induced*
  • Pemphigoid, Bullous / diagnosis
  • Pemphigoid, Bullous / immunology
  • Severity of Illness Index
  • Skin / drug effects
  • Skin / immunology
  • Skin / pathology

Substances

  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents, Immunological
  • pembrolizumab